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ABSTRACT
Objective: The purpose of this study was to determine if a dilute solution of chlorhexidine used as
a one-time vaginal wash intrapartum can reduce the use of postnatal antibiotics and neonatal
infection.
Methods: Term pregnant women in labor were prospectively randomized to receive either 20 cc
of 0.4% chlorhexidine (n 481) or 20 cc of sterile water (n 466) placebo. Exclusion criteria
included fetal distress, clinical infection, cervical dilatation >6 cm, and known allergy to chlorhex-
idine. Outcome variables included the incidence of neonatal pneumonia, culture proven neonatal
sepsis, and use of the antibiotics in the neonate. Continuous variables were compared using the
Mann-Whitney U-test and discrete variables were compared with the chi-square test.
Results: The length of ruptured membranes (mean S.D.) between the chlorhexidine group (408
589 min) and control group (352 318 min) was not significantly different (P 0.85, 95%
confidence interval 354-462). Fifteen neonates (3.2%) in the chlorhexidine group and 9 (1.9%) in
the control group received antibiotics in the postnatal period (P 0.32, 95% confidence interval
0.72-3.72). There was one case of pneumonia in the control group and no cases of sepsis in either
group.
Conclusions: A one-time chlorhexidine vaginal wash does not decrease the use of antibiotics or
incidence of neonatal infection in our population. Infect. Dis. Obstet. Gynecol. 5:286-290, 1997.
(C) 1998 Wiley-Liss, Inc.
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eonatal infections, particularly following the
diagnosis of intrapartum infection, result in
significant morbidity each year. Infants diagnosed
with probable sepsis have significantly longer hos-
pital stays and use of antibiotics leading to increas-
ing hospital costs.
More than a decade ago investigators proposed
antepartum vaginal washing with chlorhexidine as
a means of decreasing group B streptococcus (GBS)
colonization rates in neonates. 1-3 Chlorhexidine
disinfection during labor is a simple, cheap, and
safe method of reducing GBS colonization without
risk for development of bacterial resistance. An-
other advantage is that it not only can be used in
modern labor and delivery suites, but also in the
developing world.
Intrigued by these initial results and the possi-
bility that chlorhexidine might also reduce the
transmission of other potential pathogens, we pos-
tulated that this approach may decrease infectious
morbidity in neonates caused by vaginal microor-
ganisms. We have previously reported our maternal
data.4 Therefore, this study sought to determine if
a chlorhexidine vaginal wash given intrapartum can
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reduce the use of antibiotics and infectious mor-
bidity in the neonate.
SUBJECTS AND METHODS
This randomized control trial was approved by the
Committee for the Protection for Human Subjects
at the University of Texas Health Science Cen-
ter-Houston. Women admitted to the Lyndon
Baines Johnson Hospital labor and delivery room
between June 1991 through September 1992 were
considered for enrollment. Patients at 36 weeks or
greater gestational age in labor were counseled
about the study and were invited to participate.
Exclusion criteria on admission to the hospital in-
cluded preterm labor, fetal distress, malpresenta-
tion, intraamniotic infection, cervical dilatation >6
cm, and known allergy to chlorhexidine.. All pa-
tients meeting eligibility criteria were invited to
participate and written informed consent was ob-
tained from all participating women.
A computer software program (True Epistat,
Richardson, TX) was used to generate a random
block allocation sequence to assign patients to ei-
ther group. The randomization assignments were
contained in sequentially numbered, opaque,
sealed packets that were made up independent of
the physicians managing the patients. The ran-
domization was known only after the patient had
been enrolled in the study. The authors chose not
to blind the study because the syringe containing
the chlorhexidine solution was pink and we could
not reproduce the color artificially in the syringe
containing the sterile water. Additionally, the phy-
sicians managing infants in the nursery were un-
aware of which arm of the study each patient was
randomized, thus eliminating physician bias.
Patients presenting to labor and delivery who
did not have a history of rupture of the membranes
underwent a vaginal examination prior to inclusion
in the study. Women who had documented rupture
of the membranes had their cervical dilatation de-
termined by visual examination of the cervix with
a speculum. Following enrollment all patients un-
derwent a speculum examination by the admitting
resident physician. Women randomized to the
study arm received 20 cc of a 0.4% chlorhexidine
solution. The solution was placed around the portio
and fornices using a syringe. Women in the control
group were irrigated with 20 cc of sterile water.
Clinical information was abstracted from the medi-
cal record by a study nurse including demographic
information, labor characteristics, the use of antibi-
otics in the neonatal period (primary outcome), and
the incidence of neonatal infection. The data were
collected after all neonates had been discharged
from the hospital. The investigators did not know
the clinical outcome of the infants prior to the end
of the study.
The clinical diagnosis of intraamniotic infection
(IAI) was made when the patient had an intrapar-
turn temperature >100.4F with two of the follow-
ing criteria: maternal tachycardia, uterine tender-
ness, foul amniotic fluid, material leukocytosis, or
fetal tachycardia. In nearly all cases, initial therapy
consisted of parental ampicillin plus gentamicin.
A diagnosis of neonatal infection was made if
the neonate developed pneumonia or sepsis. The
diagnosis of neonatal pneumonia was made by the
attending physician if the neonate was febrile and
had chest radiograph findings consistent with the
diagnosis. Neonatal sepsis was diagnosed if the infant
had a positive blood or cerebrospinal fluid culture,
along with a clinical course consistent with sepsis.
A sample size calculation was performed based
on a prestudy neonatal antibiotic use rate of 6%. In
order to reduce the use of antibiotics to 3%, it
would require 744 patients, enrolled in each arm in
the study in order to have an 80% power with a P
< 0.05. During the study period we observed a de-
clining IAI rate in our hospital and subsequent de-
cline in the use of antibiotics in the neonatal pe-
riod, therefore, we performed an interim analysis.
Statistical analysis was performed using a computer
software package (True Epistat). Tests for normal-
ity showed that the data were not normally distrib-
uted. Continuous data were analyzed using the
Mann-Whitney U-test. Categorical data were ana-
lyzed with the chi-square test. P < 0.05 was con-
sidered statistically significant.
RESULTS
Informed consent was obtained on 1,024 women
who were eligible for the study. Of these, 77 were
excluded from the analysis for the following rea-
sons: incomplete records (71), the patient was en-
rolled and subsequently discharged home (3), vagi-
nal wash was not given (2), and a patient whose
infant had anencephaly was inadvertently enrolled
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TABLE I. Demographic data
Chlorhexidine Control
Characteristic (n 457) (n 453)
Estimated gestational
age (weeks) 39.4 + 1.5 39.3 + 2.4 0.69
Birth weight (g) 3,369 + 449 3,365 + 447 0.75
5 min Apgar <7 4 (0.9%) 6 (I.3%) 0.75
Days in hospital 2.2 + 2. 2.2 + 2.2 0.40
aData are expressed as mean + S.D., except for 5 min Apgar <7 data,
which are expressed as number (%).
(1). Of the remaining 947 patients, 481 were ran-
domized to the study arm and 466 served as con-
trois. Twenty-four neonatal charts in the chlorhex-
idine group and 13 in the control group were un-
available for review. This left 457 neonates in the
study group and 453 in a control group for analysis.
Demographic data are expressed in ,Table 1. The
two groups were similar with respect to estimated
gestational age, birth weight, Apgar score <7 at 5
min, and the number of days in the hospital.
Fifteen (3.2%) neonates in the chlorhexidine
group and 9 (1.9%) in the control group received
antibiotics (P 0.32, 95% confidence interval 0.72-
3.72). There was one case of pneumonia in the
control group and no cases of neonatal sepsis in
either group.
Patients were also analyzed for any relationship
between labor characteristics and use of antibiotics
in the neonate and the presence or absence of IAI
(Table 2). Patients with a diagnosis of IAI in either
group had a significantly longer duration of rup-
tured membranes compared to women without
IAI. The time between the vaginal wash and de-
livery was significantly greater in patients with IAI
compared to those without infection in the chlor-
hexidine group but not for controls. The number of
neonates receiving antibiotics in either group was
significantly greater if the mother had a diagnosis
of IAI.
No adverse effects of chlorhexidine prophylaxis
were observed among any neonate.
DISCUSSION
Chlorhexidine gluconate is a potent antimicrobial
agent with activity against vaginal bacteria causing
neonatal infection,s It can suppress growth of bac-
teria for up to 24 h and its effectiveness is not
reduced by the presence of blood or amniotic
fluid.l,6
Chlorhexidine applied to the vagina intrapartum
has been shown to decrease the transmission of
GBS to neonates and reduce the GBS colonization
of women in the puerperium. Chlorhexidine has
also been used as a skin and mucous membrane
disinfectant in nurseries for many years. Absorption
of chlorhexidine from intact skin is negligible and
there is virtually no acute toxicity in animal stud-
ies.7 Concentrations of up to 8% have been used for
daily bathing of neonatal monkeys as a means to
provide additional evidence of its safety as a skin
cleanser.8 Other studies show that absorption of
chlorhexidine through intact skin into the venous
blood is negligible.
9 Therefore, chlorhexidine vagi-
nal wash given intrapartum appears to be an inex-
pensive and safe antimicrobial method for poten-
tially reducing peripartum and neonatal infectious
morbidity.
The results of this study indicate that there is no
difference in the incidence in the use of antibiotics
in the neonatal period or the incidence of neonatal
infection. The use of antibiotics appeared to cor-
relate with the length of ruptured membranes as
well as presence of IAI. Both of these are known
risk factors for neonatal sepsis and pneumonia.1 In
a similar study to ours, Rouse and co-workers
showed no difference in neonatal outcomes, in-
cluding sepsis.
Several reasons could explain our findings. Per-
haps, a 10-fold dilution of the stock solution (4%) is
not an effective antimicrobial strength. Although
this possibility exits, the chlorhexidine concentra-
tion used in our study was 300 times the minimum
bactericidal concentration for the more common
neonatal pathogens. Furthermore, the concentra-
tion used in our study was somewhat higher than
what has been used in other clinical studies.-3
Another explanation for the lack of any differ-
ence between groups is the vehicle used. An aque-
ous chlorhexidine solution has been used exten-
sively by Christensen’s group, z Perhaps another
vehicle with a higher viscosity, such as a gel, might
be more adherent to the vaginal walls and thus
increase its effectiveness when compared to an
aqueous solution. Recently, these two methods
were compared. Although there was a tendency to-
ward more full-term neonates with sepsis in a
group using chlorhexidine gel, there was no differ-
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TABLE 2. Labor characteristics and use of antibiotics in the neonate compared to the incidence of IAI
Chlorhexidine Controls
IAI No IAI IAI No IAI
Characteristic (n 23) n 434) P (n 21) (n 445)
Length of ruptured membranes (min) 653 + 408 405 + 540 <0.001 560 + 373
Vaginal wash to delivery (min) 559 + 235 326 + 274 <0.001 433 + 364
Antibiotics 8 (35%) 7 (I.6%) <0.001 6 (29%)
350 + 321 0.005
312 + 260 NS
3 (0.7%) <0.001
Data are expressed as mean + S.D., except for antibiotic data, which are expressed as number (%). NS not significant.
ence in the number of neonates receiving systemic
antibiotics between the group receiving aqueous
chlorhexidine compared to chlorhexidine gel. 12
On the other hand, Christensen’s group2 de-
scribed a complex, vigorous, extensive washing
procedure of the cervix, vagina, and external geni-
tal. A beneficial effect might be ascribed to both
the mechanical cleansing effect and the antimicro-
bial action of the chlorhexidine.
There is also the possibility of a significant
washout effect of the bacteria in the placebo group
receiving normal saline. Stray-Pedersen et al. (un-
published abstract, XIII World Congress of Gyne-
cology and Obstetrics, 1991) demonstrated a sig-
nificant reduction in the transmission rate of mi-
crobes in patients receiving saline or chlorhexidine
douche compared to women who did not receive a
douche intrapartum.
In our trial, we chose to use a single vaginal
application as others have described. 1-3,1 Other
studies, analyzing the effects of vaginal washing on
neonatal morbidity, repeated the wash (every 6 h)
until delivery.
3 While future studies may later
prove this to be more beneficial, it is not practical
at our institution, since the mean time from wash to
delivery was just over 5 h.
While any study that does not demonstrate a
statistically significant difference may have a type
II error, our data have an 80% power to detect a 4%
difference in the use of systemic antibiotics in the
neonate. Thus, it is possible our sample size was
too small to detect a small difference in antibiotic
use that usually exists. Using the observed use of
antibiotics in our control group (1.9%) we would
need to enroll 2,649 patients in each arm in order to
have an 80% power. Given the magnitude of such
a study, it would not be feasible to accomplish.
Our data show that a one-time vaginal wash with
chlorhexidine does not improve neonatal outcome.
Further studies using repeated washes, mechanical
cleansing, or a different vehicle may be necessary
in order to demonstrate any difference in neonatal
outcome.
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